SpaceOAR Hydrogel For Urologists

What is SpaceOAR Hydrogel?

SpaceOAR hydrogel is an absorbable, injectable material that provides space between the rectum and prostate in men undergoing radiation therapy for prostate cancer. It is clinically proven to reduce acute and long-term rectal injury and improves Patient Report Outcomes for bowel, urinary and sexual domains.

Why Use SpaceOAR Hydrogel?

Clinical Efficacy
  • Clinically proven with a 222 patient prospective multicenter randomized study1
  • 60 clinical publications to date
  • Over 15,000 patients treated worldwide
Operational Efficiency
  • Straightforward in-office procedure
  • Performed under local anesthesia
  • Can be implanted at the time of fiducial marker placement
Reimbursement
  • The Centers for Medicare & Medicaid Services (CMS) issued the calendar year (CY) 2018 Proposed Rule that included In-Office payment of $3,879.39 for SpaceOAR hydrogel application
    • The Proposed Rule is subject to change upon Final Rule which is commonly released in November (rates typically follow but may be released as late as December).
  • New Category 1 CPT® Code effective January 1, 2018
  • New Palmetto GBA coverage decision effective October 2, 2017
  • Positive NICE guidance issued in the UK (‘standard arrangements’)
  • Use of hydrogel rectal spacer during prostate cancer therapy currently included in the 2017 NCCN Clinical Practice Guidelines in Oncology
  • Positive Health Technology Assessment report from ECRI Institute
  • Ask our team about our latest progress in obtaining coverage
  • Contact a SpaceOAR hydrogel Reimbursement Specialist at (781) 902-1657 or send us a message. 

Read how SpaceOAR  hydrogel maintains QoL at 3 Years
Post Radiation Therapy on Urology Times

 

Play the Video Below to see Marcio Fagundes, MD,

demonstrate the technique of applying SpaceOAR hydrogel

Interested in learning more?

View our clinical results
See how SpaceOAR hydrogel works
Read about SpaceOAR hydrogel in Urology Times

Questions About Reimbursement?

Learn More Here

CPT is a registered trademark of the American Medical Association’

1) N Mariados et al. Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate IMRT. Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):971-7.

2) Hamstra D, et al. Continued Benefit to Rectal Separation for Prostate RT: Final Results of a Phase III Trial. Int J Radiat Oncol Biol Phys; Dec. 2016 DOI

3) Hamstra D, et al. Evaluation of sexual function on a randomized trial of a prostate rectal spacer. J Clin Oncol 35, 2017 (suppl 6S; abstract 69)